MD, PhD, Founder
Dr. Hoeck is responsible for the overall management of Trialcare Research.
Dr. Hoeck has extensive senior clinical experience both as a clinician, scientist and as a PI on numerous studies from Phase I-IV. He has worked as a senior executive in the biopharmaceutical industry for over 15 years. His latest position was CEO of CCBR Clinical Research which under his leadership expanded to the first truly global Site Management Organization.
Dr. Hoeck founded Trialcare Research with the purpose to bridge critical gaps between science and patient care. This includes a vision to share accumulated knowledge from the biopharmaceutical industry with highly specialized colleagues within different therapeutic indications with the overall objective for their patients to have access to the newest and best therapies.
Dr. Hoeck has previously served as CEO of C4Pain, a successful niche CRO in translational medicine and he has worked extensively with private equity during changes of control and acquisitions of business targets.
Dr. Hoeck holds MD degree from the University of Southern Denmark. He is a board certified specialist in Internal Medicine, Endocrinology & Diabetes and holds a PhD in Medicine from the University of Copenhagen.